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Background
Surgery is presently playing a leading role in rectal cancer
treatment, but the natural history of the disease, featured
by a high local recurrence rate (30-40% until the 80-
90 years), suggested the possibility of using multimodal
treatment regimen : radiotherapy (before, during and
after surgery) possibly associated with chemotherapy
[1,2]. This approach is recommended for the maority of
patients with stage II (negative lymph nodes with tumor
invading the muscularis) or with stage III (positive lymph
nodes but without metastases after a time span). The
neoadjuvant radio and chemo therapy, though having no
impact on global survival rate, associated to TME reduce
the local recurrence rate, provide a higher control level of
systemic disease (micro metastases eradication), increase
the rate of complete pathological responses, and allow a
higher rate of “sphincter sparing” surgery [3,4].
Methods
From August 2006 to March 2011, 50 patients affected by
rectal cancer (adenocarcinoma, with lower margin ≤ 12
cm and the top margin ≤ 16 cm from the anal margin,
T3-4 and / or N +, M0) were treated with chemotherapy
(capecitabine) and radiotherapy (45 Gy) neo-adjuvant in
our A.O.U. Federico II; each of them underwent to sur-
gery after 5-10 weeks from the last CT-RT cycle comple-
tion. They were all studied by a multidisciplinary team
(oncologists, radiotherapists, endoscopists and surgeons).
Were excluded from our study all patients in state of
pregnancy, breast feeding, with previous or present
neoplasms, heart patients and patients with neuro-
psychic disorders or active infections. We carried out a
retrospective study in order to assess the possible differ-
ence in the occurrence of early post-operatory complica-
tions (within 30 days) in this group of 50 patients (Group
A RT-CT neo-adjuvant), and another group of 35 patients
treated in the past (even before 2006) with surgery only.
For each of them was taken into account age, gender,
ASA score, the surgery that was chosen, the tumor stage,
its position and distance from anal margin, TRG (only
for patients of Group A). The collected data were studied
through 2x2 contingency tables and statistics of c 2, the
associations between the independent variables and com-
plications were analyzed by calculating the Odds Ratio,
p values <.05 were considered statistically significant.
Results
The 2 groups were matched for age, gender, ASA, loca-
tion and stage of the cancer, the type and duration of
surgery, lenght of hospital stay. A kind of association
was highlighted between neo adjuvant therapy and
“sphincter sparing” surgery with p<.025. In A Group
78% of patients had a protective ileostomy as well, vs
42% of B Group. Although there were no statistically
significant differences, the the rate of patients showing
complicances is lower in A group (16 patients, 32%)
with respect to B Group (14 patients, 40%). In both
groups, urinary disorders are the most frequently
observed (cystitis, urinary incontinence, bladder atony,
hydronephrosis). The wound infection rate, pelvic
abscess, dehiscence of the anastomosis, post-operative
bleeding were similar in both groups; as well as with
regard to sexual dysfunction (1 case of impotence eri-
gendi in B group). Mortality rate, low in both groups,
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was of 1 case in A group and 1 case in B group, cases
anyway connected to to co-morbidity factors which
were pre-existing to surgery.
Conclusions
Our study highlights that the application of a multimo-
dal regimen to patients affected by rectal cancer , based
on neo-adjuvant chemotherapy and radiotherapy fol-
lowed by surgery after 5-10 weeks (TME) is not con-
nected to a higher risk of early complications, and in
particular does not cause any statistically significant
increase in anastomotic dehiscence. But patient condi-
tions before treatment (ASA III-IV), positive lymph
nodes are independent risk factors for the development
of complications, while the performing of a protective
ileostomy reduces the severity and at least in part the
incidence of anastomotic leakage.
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